Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
about
Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese populationShorter and sturdier bridges between traditional Chinese medicines and modern pharmacology.Examining associations between psychosis risk, social anhedonia, and performance of striatum-related behavioral tasks.The striatum: where skills and habits meet.Preserved priming effect in individuals with schizophrenia: cues towards rehabilitation.
P2860
Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@en
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@nl
type
label
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@en
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@nl
prefLabel
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@en
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@nl
P2093
P2860
P921
P1476
Dopaminergic therapy removal d ...... renia and Parkinson's disease.
@en
P2093
Jose A Apud
Llewellyn B Bigelow
Michael F Egan
Saumitra Das
Terry E Goldberg
Venkata S Mattay
P2860
P304
P356
10.1016/J.SCHRES.2013.06.028
P407
P577
2013-07-03T00:00:00Z